Skip to content Skip to sidebar Skip to footer

Tech Stocks

Test text

openai
OpenAI AI Crown Is No Longer Untouchable
OpenAI’s Reign Faces Its First Real Test Many people have heard the headlines claiming that OpenAI is calling a code red, but most still do not understand why. When we dig into the data on market share across AI model usage, a clearer picture starts to form. What investors and users should keep in mind…
telix
Telix Pharmaceuticals (ASX:TLX) Back on Track, First Patient Dosed in Phase 3 PROSTACT Trial
TLX Delivers Clinical Progress It’s good to finally see some positive news from Telix Pharmaceuticals (ASX:TLX) after a relatively quiet period, especially following recent market nerves around the FDA slowdown and a few ASX announcement missteps. Today, the company reported an important milestone in its PROSTACT Global Phase 3 trial, confirming that the first patient…

Stocks Down Under (Pitt Street Research AFSL 1265112) provides actionable investment ideas on ASX-listed stocks. This content provides general information only and does not constitute financial advice. Always do your own research before making investment decisions. © 2026 Stock Down Under. All Rights Reserved.

© 2026 Kicker. All Rights Reserved.

Add Your Heading Text Here